Trial Profile
The efficacy and safety of preoperative intravitreal conbercept (IVC) injection before vitrectomy for proliferative diabetic retinopathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Apr 2016
Price :
$35
*
At a glance
- Drugs Conbercept (Primary)
- Indications Diabetic retinopathy; Intraoperative complications; Vitreous haemorrhage
- Focus Therapeutic Use
- 28 Apr 2016 New trial record